Emanuele Vita

Università Cattolica del Sacro Cuore — Italy

Medicine · Health Sciences

14h-index835citations68works4.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lung Cancer Treatments and Mutations(29), Lung Cancer Research Studies(18), Cancer Immunotherapy and Biomarkers(17), Lung Cancer Diagnosis and Treatment(13), Colorectal Cancer Treatments and Studies(8)

Publications68 total

Oncometabolite signatures from tumor-stroma crosstalk as potential non-invasive biomarkers
2025Open Access
PI3K/mTORC2-RICTOR axis in early squamous non-small-cell lung cancer: genomics, molecular expression, and clinical relevance
Therapeutic Advances in Medical Oncology·2025Open Access
Network analysis of NRG1 variants of uncertain significance (VUSes) in advanced non-small-cell lung cancer and their prognostic role in EGFR-mutant patients treated with first-line osimertinib
ESMO Open·2025Open Access
Consolidation thoracic radiotherapy after chemoimmunotherapy in ES-SCLC: A multicentric retrospective analysis
European Journal of Cancer·2025· 6 cited
Correlation between irAEs and survival outcomes in patients with ES-SCLC treated with first-line chemoimmunotherapy
European Journal of Cancer·2025· 4 cited
COVALENCE STUDY: Immunogenicity and Reactogenicity of a COVID-19 mRNA Vaccine in an Open-Label Cohort of Long-Survivor Patients with Metastatic Lung Cancer
Vaccines·2025Open Access
312P: Correlation between immune-related adverse events (irAEs) and survival outcomes in extensive-stage small cell lung cancer (ES-SCLC) patients (pts) treated with chemoimmunotherapy (CT-IO)
Journal of Thoracic Oncology·2025
Overcoming amplification-mediated resistance to sotorasib by dose re-escalation in <i>KRAS G12C</i> mutant NSCLC: a case report
The Oncologist·2025· 2 citedOpen Access
Body composition derangements in lung cancer patients treated with first‐line pembrolizumab: A multicentre observational study
Journal of Cachexia Sarcopenia and Muscle·2024· 20 citedOpen Access
Artificial intelligence applications in personalizing lung cancer management: state of the art and future perspectives
Journal of Thoracic Disease·2024· 8 citedOpen Access
Impact of Comprehensive Genome Profiling on the Management of Advanced Non–Small Cell Lung Cancer: Preliminary Results From the Lung Cancer Cohort of the FPG500 Program
JCO Precision Oncology·2024· 6 citedOpen Access
Comparative Analysis of Comprehensive Genomic Profile in Thymomas and Recurrent Thymomas Reveals Potentially Actionable Mutations for Target Therapies
International Journal of Molecular Sciences·2024Open Access
Lazarus Response to Selpercatinib for Bleeding Colic Metastasis in a Patient With RET Fusion-Positive Pulmonary Sarcomatoid Carcinoma: A Case Report
Cureus·2024Open Access
Comparative Analysis of Comprehensive Genomic Profile in Thymomas and Recurrent Thymomas Reveals Potentially Actionable Mutations for Target Therapies
Preprints.org·2024· 2 citedOpen Access
Correlation between multiorgan immune-related adverse events and clinical outcomes in patients with extensive-stage small cell lung cancer (ES-SCLC) treated with chemo-immunotherapy.
Journal of Clinical Oncology·2024
Implementation of Artificial Intelligence in Personalized Prognostic Assessment of Lung Cancer: A Narrative Review
Cancers·2024· 31 citedOpen Access
Symptomatic androgen deficiency and sexual dysfunctions in male patients receiving alectinib for ALK‐positive advanced non–small cell lung cancer
Cancer·2024· 6 citedOpen Access
Real-world outcomes of Italian patients with advanced non-squamous lung cancer treated with first-line pembrolizumab plus platinum-pemetrexed
European Journal of Cancer·2024· 11 citedOpen Access
234P Clinical findings and genomic characterization of NRG-1 alterations with a comprehensive genome profiling (CGP) in advanced non-small cell lung cancer (ANSCLC)
ESMO Open·2024Open Access
Facial Papulopustular Eruption during the COVID-19 Pandemic in Patients Treated with EGFR Inhibitors
Dermatology Research and Practice·2024Open Access
page 1 of 4Next →

Frequent Co-authors

Emilio Bria(40), Giampaolo Tortora(25), Ettore D’Argento(17), Filippo Lococo(17), Sara Pilotto(16), Michèle Milella(14), Marco Chiappetta(13), Alessio Stefani(12), Alessandra Cancellieri(11), Miriam Grazia Ferrara(10), Jessica Evangelista(9), Mariantonietta Di Salvatore(9), Vincenzo Di Noia(8), Rocco Trisolini(8), Stefano Margaritora(8), Luca Boldrini(8), Carolina Sassorossi(8), Federico Monaca(8), Carmine Carbone(6), Diana Giannarelli(6)